
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
- COVID-19
- New Therapies and Current Patient Management of Lymphomas
- Update on Patient Care Treatment Strategies in Leukemia
- Controversies and Update for Patient Care in Multiple Myeloma
Updates on MCL: Ibrutinib + Ven, Len + Rituximab, 1L Sequential Immunochemotherapy, LOXO-305, Lisocabtagene Maraleucel
86 views
July 15, 2021
Comments 0
Login to view comments.
Click here to Login
New Therapies and Current Patient Management of Lymphomas